期刊文献+

反义寡核苷酸并超声微泡造影剂转染联合超声照射逆转肝癌多药耐药 被引量:6

Reversion of multidrug resistance of hepatocellular carcinoma by antisense oligonucleotides and ultrasonic microbubble intensifier transfection combined with ultrasound irradiation
原文传递
导出
摘要 目的探讨体内、体外mdr1、mrp、lrp反义寡核苷酸(AODNs)并超声微泡造影剂转染联合低强度超声照射逆转肝癌多药耐药的可行性,寻找逆转肿瘤多药耐药有效和靶向的方法。方法利用超声微泡造影剂包载肿瘤耐药基因mdr1、mrp、lrp的AODNs进行转染,联合低强度超声照射,以肝癌细胞多药耐药细胞模型(HepG2/ADM) 为研究对象,通过逆转录聚合酶链反应、western blot和四甲基偶氮唑盐法,从体外细胞培养及动物实验,研究 AODNs并超声微泡造影剂转染联合超声照射逆转癌细胞多药耐药及降低肿瘤恶性表型和成瘤能力的作用。结果 HepG2/AMD细胞增殖被抑制,其mdr1和mrp的mRNA、蛋白质表达水平明显降低;裸鼠皮下移植瘤生长受抑制。结论体外、体内AODNs并超声微泡造影剂转染联合低强度超声照射能有效逆转人肝癌细胞HepG2/ADM的多药耐药, 该技术可能为肝癌临床治疗提供新的思路。 Objective To study whether antisense oligonucleotides and ultrasonic microbubble intensifier transfection combined with ultrasound irradiation is an effective and directional way in reversing multidrug resistance (MDR) in tumors, Methods Mdr1, mrp, and lrp genes antisense oligonucleotides on the ultrasound microbubble intensifier were transfected for the human HepG2/ADM cell lines and then the cells were radiated with low intensity ultrasound, The effects of the reversion of carcinoma cells' MDR and the reduction of their malignancy and growth capability in vitro and in vivo were assessed using RTPCR, Western blot and MTT. Results The treatment restrained the multiplication of the human HepG2/AMD cell lines. The levels of their mRNA and protein of cells' mdr1 and mrp genes dropped significantly. Growth of the subcutaneous transplanted tumors in the nude mice decreased. Conclusions Transfection of MDR genes antisense oligonucleotides on the ultrasonic microbubble intensifier combined with low intensity ultrasound radiation may serve as a new treatment method for hepatocellular carcinoma.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2006年第5期341-345,共5页 Chinese Journal of Hepatology
关键词 肝细胞 寡核昔酸 反义 造影剂 微泡 超声 超声 低强度 多药耐药 Carcinoma, hepatocellular Antisense oligonucleotides Ultrasonic microbubble intensifier Ultrasound, low intensity Multidrug resistance
  • 相关文献

参考文献12

  • 1Thompson CB.Apoptosis in the pathogenesis and treatment of disease.Science,1995,267:1456-1462.
  • 2Litman T,Druley TE,Stein WD,et al.From MDR to MXR:new understanding of multidrug resistance systems,their properties and clinical significance.Cell Mol Life Sci,2001,58:931-959.
  • 3Zaffaroni N,Lualdi S,Villa R,et al.Inhibition of telomerase activity by a distamycin derivative:effects on cell proliferation and induction of apoptosis in human cancer cells.Eur J Cancer,2002,38:1792-1801.
  • 4He L,Liu GQ.Interaction of multidrug resistance reversal agents with Pglycoprotein ATPase activity on blood-brain barrier.Acta Pharmacol Sin,2002,23:423-429.
  • 5Fojo T,Bates S.Strategies for reversing drug resistance.Oncogene,2003,22:7512-7523.
  • 6Bodo A,Bakos E,Szeri F,et al.The role of multidrug transporters in drug availability,metabolism and toxicity.Toxicol Lett,2003,140-141:133-143.
  • 7Pan L,Tong Y,Jin Y,et al.Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdrl in vitro by antisense oligodeoxynucleotides.Chin Med J (Engl),2001,114:929-932.
  • 8Itoh M,Noutomi T,Chiba H,et al.BcI-xL antisense treatment sensitizes Bcl-xL-overexpressing squamous cell carcinoma cells to carboplatin.Oral Oncol,2002,38:752-756.
  • 9Masanek U,Stammler G,Volm M.Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of P-glycoprotein 170and PKC isoenzymes with antisense oligonucleotides.J Exp Ther Oncol,2002,2:37-41.
  • 10Tsang WP,Chau SP,Fung KP,et al.Modulation of multidrug resistance-associated protein 1 (MRP1) by p53 mutant in Saos-2 cells.Cancer Chemother Pharmacol,2003,51:161-166.

同被引文献41

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部